img

Global CD25 (IL2R alpha) ELISA Kit Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CD25 (IL2R alpha) ELISA Kit Market Research Report 2024

CD25(IL2Ra) ELISA Kit is an experimental tool used to measure the concentration of CD25 protein in a sample.
According to Mr Accuracy reports’s new survey, global CD25 (IL2R alpha) ELISA Kit market is projected to reach US$ 16 million in 2029, increasing from US$ 10 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CD25 (IL2R alpha) ELISA Kit market research.
CD25 is the α chain of IL-2 receptor, which is a part of the immunoglobulin superfamily. It plays an important role in the immune system and is mainly involved in the regulation of T cell activation and immune response. By using the CD25 ELISA kit, specific antibodies can be used to capture the CD25 protein in the sample, and then its concentration can be accurately determined by measuring the color change. The application of this kit will help in-depth study of the function and regulatory mechanism of CD25 in immune regulation, T cell activation and immune-related disease mechanisms, and provide an important tool for immunology research and clinical diagnosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CD25 (IL2R alpha) ELISA Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bio-Techne
Thermo Fisher Scientific (China) Co., Ltd.
Cell Sciences, Inc.
Assay Genie
MyBiosource, Inc.
Boster Biological Technology
Wuhan Fine Biotech Co., Ltd.
Abcam
Arigo Biolaboratories Corp.
LifeSpan BioSciences, Inc
CUSABIO
Geno Technology, Inc.
CLOUD-CLONE CORP.
RayBiotech, Inc.
Biorbyt
Biomatik
ZodelBiotec Ltd.
Innovative Research
Abbexa
Segment by Type
Human
Mouse
Rat
Others

Segment by Application


Hospital
Research Institute
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The CD25 (IL2R alpha) ELISA Kit report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 CD25 (IL2R alpha) ELISA Kit Market Overview
1.1 Product Overview and Scope of CD25 (IL2R alpha) ELISA Kit
1.2 CD25 (IL2R alpha) ELISA Kit Segment by Type
1.2.1 Global CD25 (IL2R alpha) ELISA Kit Market Value Comparison by Type (2024-2034)
1.2.2 Human
1.2.3 Mouse
1.2.4 Rat
1.2.5 Others
1.3 CD25 (IL2R alpha) ELISA Kit Segment by Application
1.3.1 Global CD25 (IL2R alpha) ELISA Kit Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global CD25 (IL2R alpha) ELISA Kit Market Size Estimates and Forecasts
1.4.1 Global CD25 (IL2R alpha) ELISA Kit Revenue 2018-2029
1.4.2 Global CD25 (IL2R alpha) ELISA Kit Sales 2018-2029
1.4.3 Global CD25 (IL2R alpha) ELISA Kit Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CD25 (IL2R alpha) ELISA Kit Market Competition by Manufacturers
2.1 Global CD25 (IL2R alpha) ELISA Kit Sales Market Share by Manufacturers (2018-2024)
2.2 Global CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Manufacturers (2018-2024)
2.3 Global CD25 (IL2R alpha) ELISA Kit Average Price by Manufacturers (2018-2024)
2.4 Global CD25 (IL2R alpha) ELISA Kit Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of CD25 (IL2R alpha) ELISA Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD25 (IL2R alpha) ELISA Kit, Product Type & Application
2.7 CD25 (IL2R alpha) ELISA Kit Market Competitive Situation and Trends
2.7.1 CD25 (IL2R alpha) ELISA Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CD25 (IL2R alpha) ELISA Kit Players Market Share by Revenue
2.7.3 Global CD25 (IL2R alpha) ELISA Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CD25 (IL2R alpha) ELISA Kit Retrospective Market Scenario by Region
3.1 Global CD25 (IL2R alpha) ELISA Kit Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global CD25 (IL2R alpha) ELISA Kit Global CD25 (IL2R alpha) ELISA Kit Sales by Region: 2018-2029
3.2.1 Global CD25 (IL2R alpha) ELISA Kit Sales by Region: 2018-2024
3.2.2 Global CD25 (IL2R alpha) ELISA Kit Sales by Region: 2024-2029
3.3 Global CD25 (IL2R alpha) ELISA Kit Global CD25 (IL2R alpha) ELISA Kit Revenue by Region: 2018-2029
3.3.1 Global CD25 (IL2R alpha) ELISA Kit Revenue by Region: 2018-2024
3.3.2 Global CD25 (IL2R alpha) ELISA Kit Revenue by Region: 2024-2029
3.4 North America CD25 (IL2R alpha) ELISA Kit Market Facts & Figures by Country
3.4.1 North America CD25 (IL2R alpha) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America CD25 (IL2R alpha) ELISA Kit Sales by Country (2018-2029)
3.4.3 North America CD25 (IL2R alpha) ELISA Kit Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD25 (IL2R alpha) ELISA Kit Market Facts & Figures by Country
3.5.1 Europe CD25 (IL2R alpha) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe CD25 (IL2R alpha) ELISA Kit Sales by Country (2018-2029)
3.5.3 Europe CD25 (IL2R alpha) ELISA Kit Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD25 (IL2R alpha) ELISA Kit Market Facts & Figures by Country
3.6.1 Asia Pacific CD25 (IL2R alpha) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific CD25 (IL2R alpha) ELISA Kit Sales by Country (2018-2029)
3.6.3 Asia Pacific CD25 (IL2R alpha) ELISA Kit Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD25 (IL2R alpha) ELISA Kit Market Facts & Figures by Country
3.7.1 Latin America CD25 (IL2R alpha) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America CD25 (IL2R alpha) ELISA Kit Sales by Country (2018-2029)
3.7.3 Latin America CD25 (IL2R alpha) ELISA Kit Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD25 (IL2R alpha) ELISA Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa CD25 (IL2R alpha) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa CD25 (IL2R alpha) ELISA Kit Sales by Country (2018-2029)
3.8.3 Middle East and Africa CD25 (IL2R alpha) ELISA Kit Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD25 (IL2R alpha) ELISA Kit Sales by Type (2018-2029)
4.1.1 Global CD25 (IL2R alpha) ELISA Kit Sales by Type (2018-2024)
4.1.2 Global CD25 (IL2R alpha) ELISA Kit Sales by Type (2024-2029)
4.1.3 Global CD25 (IL2R alpha) ELISA Kit Sales Market Share by Type (2018-2029)
4.2 Global CD25 (IL2R alpha) ELISA Kit Revenue by Type (2018-2029)
4.2.1 Global CD25 (IL2R alpha) ELISA Kit Revenue by Type (2018-2024)
4.2.2 Global CD25 (IL2R alpha) ELISA Kit Revenue by Type (2024-2029)
4.2.3 Global CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Type (2018-2029)
4.3 Global CD25 (IL2R alpha) ELISA Kit Price by Type (2018-2029)
5 Segment by Application
5.1 Global CD25 (IL2R alpha) ELISA Kit Sales by Application (2018-2029)
5.1.1 Global CD25 (IL2R alpha) ELISA Kit Sales by Application (2018-2024)
5.1.2 Global CD25 (IL2R alpha) ELISA Kit Sales by Application (2024-2029)
5.1.3 Global CD25 (IL2R alpha) ELISA Kit Sales Market Share by Application (2018-2029)
5.2 Global CD25 (IL2R alpha) ELISA Kit Revenue by Application (2018-2029)
5.2.1 Global CD25 (IL2R alpha) ELISA Kit Revenue by Application (2018-2024)
5.2.2 Global CD25 (IL2R alpha) ELISA Kit Revenue by Application (2024-2029)
5.2.3 Global CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Application (2018-2029)
5.3 Global CD25 (IL2R alpha) ELISA Kit Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bio-Techne
6.1.1 Bio-Techne Corporation Information
6.1.2 Bio-Techne Description and Business Overview
6.1.3 Bio-Techne CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Bio-Techne CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.1.5 Bio-Techne Recent Developments/Updates
6.2 Thermo Fisher Scientific (China) Co., Ltd.
6.2.1 Thermo Fisher Scientific (China) Co., Ltd. Corporation Information
6.2.2 Thermo Fisher Scientific (China) Co., Ltd. Description and Business Overview
6.2.3 Thermo Fisher Scientific (China) Co., Ltd. CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Thermo Fisher Scientific (China) Co., Ltd. CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.2.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
6.3 Cell Sciences, Inc.
6.3.1 Cell Sciences, Inc. Corporation Information
6.3.2 Cell Sciences, Inc. Description and Business Overview
6.3.3 Cell Sciences, Inc. CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Cell Sciences, Inc. CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.3.5 Cell Sciences, Inc. Recent Developments/Updates
6.4 Assay Genie
6.4.1 Assay Genie Corporation Information
6.4.2 Assay Genie Description and Business Overview
6.4.3 Assay Genie CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Assay Genie CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.4.5 Assay Genie Recent Developments/Updates
6.5 MyBiosource, Inc.
6.5.1 MyBiosource, Inc. Corporation Information
6.5.2 MyBiosource, Inc. Description and Business Overview
6.5.3 MyBiosource, Inc. CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.5.4 MyBiosource, Inc. CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.5.5 MyBiosource, Inc. Recent Developments/Updates
6.6 Boster Biological Technology
6.6.1 Boster Biological Technology Corporation Information
6.6.2 Boster Biological Technology Description and Business Overview
6.6.3 Boster Biological Technology CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Boster Biological Technology CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.6.5 Boster Biological Technology Recent Developments/Updates
6.7 Wuhan Fine Biotech Co., Ltd.
6.6.1 Wuhan Fine Biotech Co., Ltd. Corporation Information
6.6.2 Wuhan Fine Biotech Co., Ltd. Description and Business Overview
6.6.3 Wuhan Fine Biotech Co., Ltd. CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Wuhan Fine Biotech Co., Ltd. CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.7.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
6.8 Abcam
6.8.1 Abcam Corporation Information
6.8.2 Abcam Description and Business Overview
6.8.3 Abcam CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Abcam CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.8.5 Abcam Recent Developments/Updates
6.9 Arigo Biolaboratories Corp.
6.9.1 Arigo Biolaboratories Corp. Corporation Information
6.9.2 Arigo Biolaboratories Corp. Description and Business Overview
6.9.3 Arigo Biolaboratories Corp. CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Arigo Biolaboratories Corp. CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.9.5 Arigo Biolaboratories Corp. Recent Developments/Updates
6.10 LifeSpan BioSciences, Inc
6.10.1 LifeSpan BioSciences, Inc Corporation Information
6.10.2 LifeSpan BioSciences, Inc Description and Business Overview
6.10.3 LifeSpan BioSciences, Inc CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.10.4 LifeSpan BioSciences, Inc CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.10.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.11 CUSABIO
6.11.1 CUSABIO Corporation Information
6.11.2 CUSABIO CD25 (IL2R alpha) ELISA Kit Description and Business Overview
6.11.3 CUSABIO CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.11.4 CUSABIO CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.11.5 CUSABIO Recent Developments/Updates
6.12 Geno Technology, Inc.
6.12.1 Geno Technology, Inc. Corporation Information
6.12.2 Geno Technology, Inc. CD25 (IL2R alpha) ELISA Kit Description and Business Overview
6.12.3 Geno Technology, Inc. CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Geno Technology, Inc. CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.12.5 Geno Technology, Inc. Recent Developments/Updates
6.13 CLOUD-CLONE CORP.
6.13.1 CLOUD-CLONE CORP. Corporation Information
6.13.2 CLOUD-CLONE CORP. CD25 (IL2R alpha) ELISA Kit Description and Business Overview
6.13.3 CLOUD-CLONE CORP. CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.13.4 CLOUD-CLONE CORP. CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.13.5 CLOUD-CLONE CORP. Recent Developments/Updates
6.14 RayBiotech, Inc.
6.14.1 RayBiotech, Inc. Corporation Information
6.14.2 RayBiotech, Inc. CD25 (IL2R alpha) ELISA Kit Description and Business Overview
6.14.3 RayBiotech, Inc. CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.14.4 RayBiotech, Inc. CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.14.5 RayBiotech, Inc. Recent Developments/Updates
6.15 Biorbyt
6.15.1 Biorbyt Corporation Information
6.15.2 Biorbyt CD25 (IL2R alpha) ELISA Kit Description and Business Overview
6.15.3 Biorbyt CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Biorbyt CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.15.5 Biorbyt Recent Developments/Updates
6.16 Biomatik
6.16.1 Biomatik Corporation Information
6.16.2 Biomatik CD25 (IL2R alpha) ELISA Kit Description and Business Overview
6.16.3 Biomatik CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Biomatik CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.16.5 Biomatik Recent Developments/Updates
6.17 ZodelBiotec Ltd.
6.17.1 ZodelBiotec Ltd. Corporation Information
6.17.2 ZodelBiotec Ltd. CD25 (IL2R alpha) ELISA Kit Description and Business Overview
6.17.3 ZodelBiotec Ltd. CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.17.4 ZodelBiotec Ltd. CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.17.5 ZodelBiotec Ltd. Recent Developments/Updates
6.18 Innovative Research
6.18.1 Innovative Research Corporation Information
6.18.2 Innovative Research CD25 (IL2R alpha) ELISA Kit Description and Business Overview
6.18.3 Innovative Research CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Innovative Research CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.18.5 Innovative Research Recent Developments/Updates
6.19 Abbexa
6.19.1 Abbexa Corporation Information
6.19.2 Abbexa CD25 (IL2R alpha) ELISA Kit Description and Business Overview
6.19.3 Abbexa CD25 (IL2R alpha) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Abbexa CD25 (IL2R alpha) ELISA Kit Product Portfolio
6.19.5 Abbexa Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD25 (IL2R alpha) ELISA Kit Industry Chain Analysis
7.2 CD25 (IL2R alpha) ELISA Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD25 (IL2R alpha) ELISA Kit Production Mode & Process
7.4 CD25 (IL2R alpha) ELISA Kit Sales and Marketing
7.4.1 CD25 (IL2R alpha) ELISA Kit Sales Channels
7.4.2 CD25 (IL2R alpha) ELISA Kit Distributors
7.5 CD25 (IL2R alpha) ELISA Kit Customers
8 CD25 (IL2R alpha) ELISA Kit Market Dynamics
8.1 CD25 (IL2R alpha) ELISA Kit Industry Trends
8.2 CD25 (IL2R alpha) ELISA Kit Market Drivers
8.3 CD25 (IL2R alpha) ELISA Kit Market Challenges
8.4 CD25 (IL2R alpha) ELISA Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global CD25 (IL2R alpha) ELISA Kit Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global CD25 (IL2R alpha) ELISA Kit Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global CD25 (IL2R alpha) ELISA Kit Market Competitive Situation by Manufacturers in 2022
Table 4. Global CD25 (IL2R alpha) ELISA Kit Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global CD25 (IL2R alpha) ELISA Kit Sales Market Share by Manufacturers (2018-2024)
Table 6. Global CD25 (IL2R alpha) ELISA Kit Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global CD25 (IL2R alpha) ELISA Kit Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market CD25 (IL2R alpha) ELISA Kit Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of CD25 (IL2R alpha) ELISA Kit, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of CD25 (IL2R alpha) ELISA Kit, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD25 (IL2R alpha) ELISA Kit, Product Type & Application
Table 12. Global Key Manufacturers of CD25 (IL2R alpha) ELISA Kit, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD25 (IL2R alpha) ELISA Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD25 (IL2R alpha) ELISA Kit as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD25 (IL2R alpha) ELISA Kit Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global CD25 (IL2R alpha) ELISA Kit Sales by Region (2018-2024) & (K Units)
Table 18. Global CD25 (IL2R alpha) ELISA Kit Sales Market Share by Region (2018-2024)
Table 19. Global CD25 (IL2R alpha) ELISA Kit Sales by Region (2024-2029) & (K Units)
Table 20. Global CD25 (IL2R alpha) ELISA Kit Sales Market Share by Region (2024-2029)
Table 21. Global CD25 (IL2R alpha) ELISA Kit Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Region (2018-2024)
Table 23. Global CD25 (IL2R alpha) ELISA Kit Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Region (2024-2029)
Table 25. North America CD25 (IL2R alpha) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America CD25 (IL2R alpha) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 27. North America CD25 (IL2R alpha) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 28. North America CD25 (IL2R alpha) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America CD25 (IL2R alpha) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe CD25 (IL2R alpha) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe CD25 (IL2R alpha) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 32. Europe CD25 (IL2R alpha) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 33. Europe CD25 (IL2R alpha) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe CD25 (IL2R alpha) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific CD25 (IL2R alpha) ELISA Kit Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific CD25 (IL2R alpha) ELISA Kit Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific CD25 (IL2R alpha) ELISA Kit Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific CD25 (IL2R alpha) ELISA Kit Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific CD25 (IL2R alpha) ELISA Kit Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America CD25 (IL2R alpha) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America CD25 (IL2R alpha) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 42. Latin America CD25 (IL2R alpha) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 43. Latin America CD25 (IL2R alpha) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America CD25 (IL2R alpha) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa CD25 (IL2R alpha) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa CD25 (IL2R alpha) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa CD25 (IL2R alpha) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa CD25 (IL2R alpha) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa CD25 (IL2R alpha) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global CD25 (IL2R alpha) ELISA Kit Sales (K Units) by Type (2018-2024)
Table 51. Global CD25 (IL2R alpha) ELISA Kit Sales (K Units) by Type (2024-2029)
Table 52. Global CD25 (IL2R alpha) ELISA Kit Sales Market Share by Type (2018-2024)
Table 53. Global CD25 (IL2R alpha) ELISA Kit Sales Market Share by Type (2024-2029)
Table 54. Global CD25 (IL2R alpha) ELISA Kit Revenue (US$ Million) by Type (2018-2024)
Table 55. Global CD25 (IL2R alpha) ELISA Kit Revenue (US$ Million) by Type (2024-2029)
Table 56. Global CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Type (2018-2024)
Table 57. Global CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Type (2024-2029)
Table 58. Global CD25 (IL2R alpha) ELISA Kit Price (US$/Unit) by Type (2018-2024)
Table 59. Global CD25 (IL2R alpha) ELISA Kit Price (US$/Unit) by Type (2024-2029)
Table 60. Global CD25 (IL2R alpha) ELISA Kit Sales (K Units) by Application (2018-2024)
Table 61. Global CD25 (IL2R alpha) ELISA Kit Sales (K Units) by Application (2024-2029)
Table 62. Global CD25 (IL2R alpha) ELISA Kit Sales Market Share by Application (2018-2024)
Table 63. Global CD25 (IL2R alpha) ELISA Kit Sales Market Share by Application (2024-2029)
Table 64. Global CD25 (IL2R alpha) ELISA Kit Revenue (US$ Million) by Application (2018-2024)
Table 65. Global CD25 (IL2R alpha) ELISA Kit Revenue (US$ Million) by Application (2024-2029)
Table 66. Global CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Application (2018-2024)
Table 67. Global CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Application (2024-2029)
Table 68. Global CD25 (IL2R alpha) ELISA Kit Price (US$/Unit) by Application (2018-2024)
Table 69. Global CD25 (IL2R alpha) ELISA Kit Price (US$/Unit) by Application (2024-2029)
Table 70. Bio-Techne Corporation Information
Table 71. Bio-Techne Description and Business Overview
Table 72. Bio-Techne CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Bio-Techne CD25 (IL2R alpha) ELISA Kit Product
Table 74. Bio-Techne Recent Developments/Updates
Table 75. Thermo Fisher Scientific (China) Co., Ltd. Corporation Information
Table 76. Thermo Fisher Scientific (China) Co., Ltd. Description and Business Overview
Table 77. Thermo Fisher Scientific (China) Co., Ltd. CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Thermo Fisher Scientific (China) Co., Ltd. CD25 (IL2R alpha) ELISA Kit Product
Table 79. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
Table 80. Cell Sciences, Inc. Corporation Information
Table 81. Cell Sciences, Inc. Description and Business Overview
Table 82. Cell Sciences, Inc. CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Cell Sciences, Inc. CD25 (IL2R alpha) ELISA Kit Product
Table 84. Cell Sciences, Inc. Recent Developments/Updates
Table 85. Assay Genie Corporation Information
Table 86. Assay Genie Description and Business Overview
Table 87. Assay Genie CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Assay Genie CD25 (IL2R alpha) ELISA Kit Product
Table 89. Assay Genie Recent Developments/Updates
Table 90. MyBiosource, Inc. Corporation Information
Table 91. MyBiosource, Inc. Description and Business Overview
Table 92. MyBiosource, Inc. CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. MyBiosource, Inc. CD25 (IL2R alpha) ELISA Kit Product
Table 94. MyBiosource, Inc. Recent Developments/Updates
Table 95. Boster Biological Technology Corporation Information
Table 96. Boster Biological Technology Description and Business Overview
Table 97. Boster Biological Technology CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Boster Biological Technology CD25 (IL2R alpha) ELISA Kit Product
Table 99. Boster Biological Technology Recent Developments/Updates
Table 100. Wuhan Fine Biotech Co., Ltd. Corporation Information
Table 101. Wuhan Fine Biotech Co., Ltd. Description and Business Overview
Table 102. Wuhan Fine Biotech Co., Ltd. CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Wuhan Fine Biotech Co., Ltd. CD25 (IL2R alpha) ELISA Kit Product
Table 104. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 105. Abcam Corporation Information
Table 106. Abcam Description and Business Overview
Table 107. Abcam CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Abcam CD25 (IL2R alpha) ELISA Kit Product
Table 109. Abcam Recent Developments/Updates
Table 110. Arigo Biolaboratories Corp. Corporation Information
Table 111. Arigo Biolaboratories Corp. Description and Business Overview
Table 112. Arigo Biolaboratories Corp. CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Arigo Biolaboratories Corp. CD25 (IL2R alpha) ELISA Kit Product
Table 114. Arigo Biolaboratories Corp. Recent Developments/Updates
Table 115. LifeSpan BioSciences, Inc Corporation Information
Table 116. LifeSpan BioSciences, Inc Description and Business Overview
Table 117. LifeSpan BioSciences, Inc CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. LifeSpan BioSciences, Inc CD25 (IL2R alpha) ELISA Kit Product
Table 119. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 120. CUSABIO Corporation Information
Table 121. CUSABIO Description and Business Overview
Table 122. CUSABIO CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. CUSABIO CD25 (IL2R alpha) ELISA Kit Product
Table 124. CUSABIO Recent Developments/Updates
Table 125. Geno Technology, Inc. Corporation Information
Table 126. Geno Technology, Inc. Description and Business Overview
Table 127. Geno Technology, Inc. CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Geno Technology, Inc. CD25 (IL2R alpha) ELISA Kit Product
Table 129. Geno Technology, Inc. Recent Developments/Updates
Table 130. CLOUD-CLONE CORP. Corporation Information
Table 131. CLOUD-CLONE CORP. Description and Business Overview
Table 132. CLOUD-CLONE CORP. CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. CLOUD-CLONE CORP. CD25 (IL2R alpha) ELISA Kit Product
Table 134. CLOUD-CLONE CORP. Recent Developments/Updates
Table 135. RayBiotech, Inc. Corporation Information
Table 136. RayBiotech, Inc. Description and Business Overview
Table 137. RayBiotech, Inc. CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. RayBiotech, Inc. CD25 (IL2R alpha) ELISA Kit Product
Table 139. RayBiotech, Inc. Recent Developments/Updates
Table 140. Biorbyt Corporation Information
Table 141. Biorbyt Description and Business Overview
Table 142. Biorbyt CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Biorbyt CD25 (IL2R alpha) ELISA Kit Product
Table 144. Biorbyt Recent Developments/Updates
Table 145. Biomatik Corporation Information
Table 146. Biomatik Description and Business Overview
Table 147. Biomatik CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Biomatik CD25 (IL2R alpha) ELISA Kit Product
Table 149. Biomatik Recent Developments/Updates
Table 150. ZodelBiotec Ltd. Corporation Information
Table 151. ZodelBiotec Ltd. Description and Business Overview
Table 152. ZodelBiotec Ltd. CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. ZodelBiotec Ltd. CD25 (IL2R alpha) ELISA Kit Product
Table 154. ZodelBiotec Ltd. Recent Developments/Updates
Table 155. Innovative Research Corporation Information
Table 156. Innovative Research Description and Business Overview
Table 157. Innovative Research CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Innovative Research CD25 (IL2R alpha) ELISA Kit Product
Table 159. Innovative Research Recent Developments/Updates
Table 160. Abbexa Corporation Information
Table 161. Abbexa Description and Business Overview
Table 162. Abbexa CD25 (IL2R alpha) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Abbexa CD25 (IL2R alpha) ELISA Kit Product
Table 164. Abbexa Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. CD25 (IL2R alpha) ELISA Kit Distributors List
Table 168. CD25 (IL2R alpha) ELISA Kit Customers List
Table 169. CD25 (IL2R alpha) ELISA Kit Market Trends
Table 170. CD25 (IL2R alpha) ELISA Kit Market Drivers
Table 171. CD25 (IL2R alpha) ELISA Kit Market Challenges
Table 172. CD25 (IL2R alpha) ELISA Kit Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of CD25 (IL2R alpha) ELISA Kit
Figure 2. Global CD25 (IL2R alpha) ELISA Kit Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global CD25 (IL2R alpha) ELISA Kit Market Share by Type in 2022 & 2029
Figure 4. Human Product Picture
Figure 5. Mouse Product Picture
Figure 6. Rat Product Picture
Figure 7. Others Product Picture
Figure 8. Global CD25 (IL2R alpha) ELISA Kit Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global CD25 (IL2R alpha) ELISA Kit Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Research Institute
Figure 12. Others
Figure 13. Global CD25 (IL2R alpha) ELISA Kit Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global CD25 (IL2R alpha) ELISA Kit Market Size (2018-2029) & (US$ Million)
Figure 15. Global CD25 (IL2R alpha) ELISA Kit Sales (2018-2029) & (K Units)
Figure 16. Global CD25 (IL2R alpha) ELISA Kit Average Price (US$/Unit) & (2018-2029)
Figure 17. CD25 (IL2R alpha) ELISA Kit Report Years Considered
Figure 18. CD25 (IL2R alpha) ELISA Kit Sales Share by Manufacturers in 2022
Figure 19. Global CD25 (IL2R alpha) ELISA Kit Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest CD25 (IL2R alpha) ELISA Kit Players: Market Share by Revenue in 2022
Figure 21. CD25 (IL2R alpha) ELISA Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global CD25 (IL2R alpha) ELISA Kit Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America CD25 (IL2R alpha) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 24. North America CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 25. United States CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe CD25 (IL2R alpha) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 28. Europe CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 29. Germany CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific CD25 (IL2R alpha) ELISA Kit Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Region (2018-2029)
Figure 36. China CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America CD25 (IL2R alpha) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 44. Latin America CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 45. Mexico CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa CD25 (IL2R alpha) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa CD25 (IL2R alpha) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 50. Turkey CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE CD25 (IL2R alpha) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of CD25 (IL2R alpha) ELISA Kit by Type (2018-2029)
Figure 54. Global Revenue Market Share of CD25 (IL2R alpha) ELISA Kit by Type (2018-2029)
Figure 55. Global CD25 (IL2R alpha) ELISA Kit Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of CD25 (IL2R alpha) ELISA Kit by Application (2018-2029)
Figure 57. Global Revenue Market Share of CD25 (IL2R alpha) ELISA Kit by Application (2018-2029)
Figure 58. Global CD25 (IL2R alpha) ELISA Kit Price (US$/Unit) by Application (2018-2029)
Figure 59. CD25 (IL2R alpha) ELISA Kit Value Chain
Figure 60. CD25 (IL2R alpha) ELISA Kit Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed